AVTN-30X

N/A

Report date: 2025/01/26 13:53:42
NME

Base Information

Drug NameAVTN-30X
Drug Alias NameAVTN-30XAVTN30X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCachexiaSarcopenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAventi Biotechnology Inc
China Registration ClassN/A

Develop Information

Active CompaniesAventi Biotechnology Inc
Inactive CompaniesN/A
Active IndicationsCachexiaSarcopenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A